2014
DOI: 10.4324/9781315073323
|View full text |Cite
|
Sign up to set email alerts
|

Collected Writings of P.G. O'Neill

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
7
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(10 citation statements)
references
References 0 publications
0
7
0
Order By: Relevance
“…That said, these numbers are poised to increase in the coming years as cell-based and cell-free technologies for glycoengineering recombinant vaccines, such as those described here and elsewhere, 25 reach full maturity. As part of this maturation, it is imperative to continue growing the pipeline with as many promising anti-bacterial vaccine candidates as possible, especially as diarrheal and other vaccinepreventable diseases continue to be unmet challenges and as drug-resistant bacteria are predicted to threaten up to 10 million lives per year by 2050 44 . Second, all ETEC vaccines to enter clinical testing thus far are focused on the classical paradigm of ETEC pathogenesis and attempt to induce immune responses to select colonization factor (CF/CS) antigens and LT [8][9][10][11] .…”
Section: Discussionmentioning
confidence: 99%
“…That said, these numbers are poised to increase in the coming years as cell-based and cell-free technologies for glycoengineering recombinant vaccines, such as those described here and elsewhere, 25 reach full maturity. As part of this maturation, it is imperative to continue growing the pipeline with as many promising anti-bacterial vaccine candidates as possible, especially as diarrheal and other vaccinepreventable diseases continue to be unmet challenges and as drug-resistant bacteria are predicted to threaten up to 10 million lives per year by 2050 44 . Second, all ETEC vaccines to enter clinical testing thus far are focused on the classical paradigm of ETEC pathogenesis and attempt to induce immune responses to select colonization factor (CF/CS) antigens and LT [8][9][10][11] .…”
Section: Discussionmentioning
confidence: 99%
“…We documented whether studies were focused on populations who are at risk or experiencing barriers to health and social care or health inequities across age, gender or sex, ethnicity, income, or other factors. We used the PROGRESS-Plus acronym to describe factors associated with health inequities (O'Neill, 2014).…”
Section: Equity Analysismentioning
confidence: 99%
“…We used the PROGRESS Plus framework (O'Neill, 2014) to guide data extraction of participant characteristics of eligible and targeted populations within the included studies. We hoped to use this information to describe and assess categories of disadvantage based around place of residence, race/ethnicity, occupation, gender, religion, education, socioeconomic status, social capital, other personal characteristics, for example, cognitive decline, and relationship features, however, the information we were able to retrieve was very limited.…”
Section: Equity Characteristicsmentioning
confidence: 99%
“…We used the progress plus framework (O'Neill, 2014) , increased intergenerational understanding (Underwood, 2006;Zucchero, 2010), appreciation of the opportunity to share stories (Chonody, 2013), opportunity to serve as a role model and mentor and form mutual relationships (Zucchero, 2010), and decreased depressive symptoms . Given that both life review through writing and intergenerational programs offer therapeutic benefits for older adults, combining the two interventions may multiply their benefits.…”
Section: Equitymentioning
confidence: 99%